Surgical treatment for epilepsy remains underutilized, in part because of persistent
misconceptions. Rather than promote referral for surgery, it would be more appropriate to …

One-third of persons with epilepsy have seizures despite appropriate medical therapy. Drug
resistant epilepsy (DRE) is associated with neurocognitive and psychological decline, poor …

Treatment goals for epilepsy are no seizures, no side effects, as soon as possible, but these
goals are too often unmet. Approximately 1 million people in the United States continue to …

Objective We reviewed data on the epidemiology of epilepsy in the United States and
estimated the prevalence and incidence of drug-resistant temporal lobe epilepsy (TLE) due …

Objective Resective surgery is effective in treating drug-resistant focal epilepsy, but it
remains unclear whether improved diagnostics influence postsurgical outcomes. Here, we …

Findings from randomised controlled trials, along with more than 100 case series and
observational studies, support the efficacy and safety of resective surgery and, more …

Introduction Despite the success of epilepsy surgery, recent reports suggest a decline in
surgical numbers. We tested these trends in our cohort to elucidate potential reasons …

With a prevalence of 0.8 to 1.2%, epilepsy represents one of the most frequent chronic
neurological disorders; 30 to 40% of patients suffer from drug-resistant epilepsy (that is …

BACKGROUND For patients with focal drug-resistant epilepsy (DRE), surgical resection of
the epileptogenic zone (EZ) may offer seizure freedom and benefits for quality of life. Yet …

Background and Objectives Patients with drug-resistant epilepsy (DRE) may benefit from
specialized testing and treatments to better control seizures and improve quality of life. Most …